AI is transforming the landscape of drug discovery and development with unprecedented speed and precision. This session details the AI advantage that is revolutionizing the field of novel therapeutics. Topics of discussion will include:

• Detailing how AI offers precision and speed in the discovery and development of targeted, effective, personalized treatments
• Uncovering the ways in which AI algorithms and machine learning are accelerating the discovery of new drugs, optimizing development pathways, and predicting patient responses
• Understanding the role of machine learning in improving the predictability of drug efficacy and safety in the pre-clinical stage
• Evaluating AI’s impact on transactions, M&A and investment trends
  • Risk assessment and due diligence in AI ventures
• Navigating unique deal terms in AI transactions
  • Exploring how AI-related transactions are developing unique deal structures
  • Data ownership, usage rights, and the financial implications of each
• Leveraging AI to design more efficient clinical trials, enhance patient selection, and monitor real-time data
• Addressing ethical, legal, and practical challenges of using large datasets in AI
  • Data privacy, quality, and integration